The prevailing hypothesis that atherosclerosis is a Th1 disease is supported by studies in which mice lacking IFN-γ or the IFN-γ receptor, TNF-α, or the Th1 transcription factor T-bet have reduced atherosclerosis [14–16]. This evidence concerns the gene IFNG and atherosclerosis.